3-hydroxy-DL-Kynurenine
Modify Date: 2025-09-17 22:37:24
3-hydroxy-DL-Kynurenine structure
|
Common Name | 3-hydroxy-DL-Kynurenine | ||
|---|---|---|---|---|
| CAS Number | 484-78-6 | Molecular Weight | 224.21300 | |
| Density | 1.461g/cm3 | Boiling Point | 519.3ºC at 760mmHg | |
| Molecular Formula | C10H12N2O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 267.9ºC | |
Use of 3-hydroxy-DL-Kynurenine3-Hydroxykynurenine, a metabolite of tryptophan, is a potential endogenous neurotoxin whose increased levels have been described in several neurodegenerative disorders. 3-Hydroxykynurenine induces neuronal apoptosis[1]. |
| Name | 3-hydroxykynurenine |
|---|---|
| Synonym | More Synonyms |
| Description | 3-Hydroxykynurenine, a metabolite of tryptophan, is a potential endogenous neurotoxin whose increased levels have been described in several neurodegenerative disorders. 3-Hydroxykynurenine induces neuronal apoptosis[1]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vitro | 3-Hydroxykynurenine-induced neuronal cell death shows several features of apoptosis[1]. 3-Hydroxykynurenine is a metabolic intermediate of the kynurenine pathway, the major metabolic pathway of tryptophan (Trp)[1]. 3-Hydroxykynurenine acts as an endogenous neurotoxin in the brain under pathological conditions[1]. 3-Hydroxykynurenine (20-100 μM) significantly inhibits CD4+ T-cell proliferation in a dose-dependent manner with IC50 of approximately 70 μM[2]. 3-Hydroxykynurenine (20-100 μM) induces significant CD4+ T-cell-mediated cell death in a dose-dependent manner[2]. Cell Proliferation Assay[2] Cell Line: CD3/CD28 bead-stimulated CD4+ T cells Concentration: 0, 20, 40, 60, 80, and 100 μM Incubation Time: 72 hours Result: Significantly inhibited CD4+ T-cell proliferation in a dose-dependent manner with an IC50 of approximately 70 μM. |
| In Vivo | 3-Hydroxykynurenine administration (560 mg/kg IP on a daily basis on days 1 to 7, days 7 to 14, or days 1 to 14) results in significant prolongation of graft survival whether administered between days 1 to 7, days 7 to 14, or days 1 to 14[2]. Animal Model: BALB/c (H2d) mice[2] Dosage: 560 mg/kg Administration: IP injection Result: There was significant prolongation of graft survival in all treatment groups in comparison to the controls. |
| References |
| Density | 1.461g/cm3 |
|---|---|
| Boiling Point | 519.3ºC at 760mmHg |
| Molecular Formula | C10H12N2O4 |
| Molecular Weight | 224.21300 |
| Flash Point | 267.9ºC |
| Exact Mass | 224.08000 |
| PSA | 126.64000 |
| LogP | 1.24060 |
| Vapour Pressure | 1.49E-12mmHg at 25°C |
| Index of Refraction | 1.635 |
| InChIKey | VCKPUUFAIGNJHC-UHFFFAOYSA-N |
| SMILES | Nc1c(O)cccc1C(=O)CC(N)C(=O)O |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| HS Code | 2922509090 |
|---|
| HS Code | 2922509090 |
|---|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| rac 3-Hydroxy Kynurenine |
| Benzenebutanoic acid, a,2-diamino-3-hydroxy-g-oxo- |